If you've been following the weight loss drug space, one name is dominating headlines in 2026: <a href="https://orforglipron.at/" rel="noopener noreferrer" target="_blank" style="background-color: transparent; color: rgb(17, 85, 204);">orforglipron</a>. Sold under the brand name Founday , this once-daily oral pill developed by Eli Lilly is the first GLP-1 receptor agonist for weight loss that can be taken at any time of day — with or without food or water restrictions. The FDA gave it the green light on April 1, 2026, and the buzz hasn't stopped since. Here's everything you need to know.

If you've been following the weight loss drug space, one name is dominating headlines in 2026: orforglipron. Sold under the brand name Founday , this once-daily oral pill developed by Eli Lilly is the first GLP-1 receptor agonist for weight loss that can be taken at any time of day — with or without food or water restrictions. The FDA gave it the green light on April 1, 2026, and the buzz hasn't stopped since. Here's everything you need to know.

gesundheitlichen Risiken

Orforglipron

Neben den rechtlichen Konsequenzen sind die gesundheitlichen Risiken von anabolen Steroiden erheblich – besonders bei unkontrolliertem, selbst verordnetem Gebrauch.

Neben den rechtlichen Konsequenzen sind die gesundheitlichen Risiken von anabolen Steroiden erheblich – besonders bei unkontrolliertem, selbst verordnetem Gebrauch.

About

Orforglipron